Adverse Events Associated with Antipsychotic Use in Hospitalized Older Adults After Cardiac Surgery.
Adverse Events Associated with Antipsychotic Use in Hospitalized Older Adults After Cardiac Surgery.
复制标题
DOI:
10.1111/jgs.14768
复制
发表时间:
2017-06
影响因子:
6.3
通讯作者:
Bateman BT
中科院分区:
文献类型:
--
作者:
Kim DH;Huybrechts KF;Patorno E;Marcantonio ER;Park Y;Levin R;Abdurrob A;Bateman BT
To evaluate in-hospital adverse events associated with typical and atypical antipsychotic drugs after cardiac surgery. Retrospective cohort study United States nationwide inpatient database, 2003–2014 3,706 patients (mean age, 70 years) newly treated with oral atypical antipsychotic drugs (N=2,580) vs. oral typical antipsychotic drugs (N=1,126) after coronary artery bypass grafting or valve surgery. In-hospital mortality, arrhythmia, pneumonia, use of brain imaging (surrogate for over-sedation and neurologic events), and length of stay after drug initiation In the propensity-score matched cohort, the median treatment duration was 3 days (interquartile range [IQR], 1 to 6 days) for atypical drugs and 2 days (IQR, 1 to 3 days) for typical drugs. There were no large differences in in-hospital mortality (atypical vs. typical drugs: 5.4% vs. 5.3%; risk difference [RD], 0.1%; 95% confidence interval [CI], −2.1 to 2.3), arrhythmia (2.0% vs. 2.2%; RD, 0.0%; 95% CI, −1.4 to 1.4), pneumonia (16.1% vs. 14.5%; RD, 1.6%; 95% CI, −1.9 to 5.0), and length of stay (9.9 days vs. 9.3 days; mean difference, 0.5 days; 95% CI, −1.2 to 2.2). Use of brain imaging, however, was more common after initiating atypical drugs relative to typical drugs (17.3% vs. 12.4%; RD, 4.9%; 95% CI, 1.4 to 8.4). In hospitalized patients who underwent cardiac surgery, short-term use of typical antipsychotic drugs was associated with similar risks of adverse events compared with atypical drugs. Moreover, increased use of brain imaging associated with atypical drugs suggests that these drugs may cause over-sedation or adverse neurologic events. Due to the relatively low event rates, however, our analysis could not exclude modest differences in adverse events between atypical and typical drugs.